Base · 44 · Common · 1999
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium26 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $300 $153–$443 | 86.0× | 2,231 | 0 |
| ▶PSA 9 | $44.00 $26.00–$60.00 | 12.6× | 4,742 | 2,231 |
| ▶PSA 8.5 | $25.48 | 7.3× | 17 | 6,973 |
| ▶PSA 8 | $31.50 $20.00–$45.00 from sold comps | 9.0× | 2,923 | 6,990 |
| ▶PSA 7 | $29.99 $25.00–$35.87 | 8.6× | 1,426 | 9,915 |
| ▶PSA 6 | $23.00 $10.50–$26.99 | 6.6× | 865 | 11,342 |
| ▶PSA 5 | $19.99 $15.00–$29.99 from sold comps | 5.7× | 626 | 12,208 |
| ▶PSA 4 | $27.47 | 7.9× | 248 | 12,834 |
| ▶PSA 3 | $98.27 unverified | 28.2× | 111 | 13,082 |
| ▶PSA 2 | $15.51 unverified | 4.4× | 46 | 13,193 |
| ▶PSA 1 | $49.98 unverified | 14.3× | 64 | 13,241 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 9.5 | $130 | 37.3× | — | — |
| ▶BGS 9 | $32.76 | 9.4× | — | — |
| ▶BGS 8.5 | $33.95 | 9.7× | — | — |
| ▶BGS 8 | $11.00 | 3.2× | — | — |
| ▶BGS 7.5 | $32.00 | 9.2× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $113 | 32.3× | — | — |
| ▶CGC 9.5 | $37.98 | 10.9× | — | — |
| ▶CGC 9 | $23.54 | 6.7× | — | — |
| ▶CGC 8.5 | $24.80 | 7.1× | — | — |
| ▶CGC 8 | $22.53 | 6.5× | — | — |
| ▶CGC 7.5 | $15.90 | 4.6× | — | — |
| ▶CGC 7 | $13.02 | 3.7× | — | — |
| ▶CGC 6.5 | $8.98 | 2.6× | — | — |
| ▶CGC 6 | $18.20 | 5.2× | — | — |
| ▶CGC 5.5 | $10.91 | 3.1× | — | — |
| ▶CGC 5 | $13.00 | 3.7× | — | — |
| ▶CGC 4.5 | $9.02 | 2.6× | — | — |
| ▶CGC 3.5 | $7.00 | 2.0× | — | — |
A model's opinion, not investment advice.